Impaired cerebromicrovascular perfusion: Summary of evidence in support of its causality in Alzheimer's disease

Annals of the New York Academy of Sciences

Volumn 924, Issue , 2000, Pages 136-152

  De La Torre, J C ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Aging; Alzheimer pathogenesis; Cerebral blood flow; Cerebral hypoperfusion; Energy metabolism; Glucose; Vascular risk factor

Indexed keywords

APOLIPOPROTEIN E4; GLUCOSE; PRESENILIN 1; VASCULOTROPIN;

AGING; ALZHEIMER DISEASE; BRAIN BLOOD FLOW; BRAIN PERFUSION; COGNITION; CONFERENCE PAPER; ENERGY METABOLISM; GENETIC RISK; GLUCOSE TRANSPORT; LEWY BODY; MICROVASCULATURE; NERVE CELL DEGENERATION; NEUROFIBRILLARY TANGLE; NEUROTRANSMISSION; OXYGEN TRANSPORT; SENILE PLAQUE; SYNAPTOGENESIS; VASCULAR AMYLOIDOSIS;

EID: 0034502476     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2000.tb05572.x     Document Type: Conference Paper

References (81)

1. Can disturbed brain rnicrocirculation cause Alzheimer's disease?
2. Cerebral hypoperfusion, capillary degeneration, and development of Alzheimer's disease
3. Cerebromicrovascular pathology in Alzheimer's disease compared to normal aging
4. Paradoxical hippocampal perfusion in mild-to-moderate Alzheimer's disease
5. Correlates between NMR spectroscopy diffusion weighted imaging and CA1 morphometry following chronic brain ischemia
6. Cerebral microvascular breakdown in dementias and after experimental cerebral hypoperfusion
7. Cerebral hypoperfusion yields capillary damage in hippocampus CA1 that correlates to spatial memory impairment
8. Vascular basement membrane components and the lesions of Alzheimer's disease
9. Thickening of the basement membrane of cortical capillaries in Alzheimer's disease
10. Microvascular changes in Alzheimer's disease
11. Pathological alterations of the cerebral microvasculature in Alzheimer's disease and related demented disorders
12. Differential degeneration of the cerebral microvasculature in Alzheimer's disease
13. Differences in the pattern of hippocampal neuronal loss in normal aging and Alzheimer's disease
14. Contribution of structural neuroimaging to the early diagnosis of Alzheimer's disease
15. Decreses in regional cerebral blood flow with normal aging
16. Cerebrovascular changes in the aging brain
17. Evaluation of estrogen treatment in female patients with dementia of the Alzheimer type
18. Effects of ovariectomy on cerebral flow in rats
19. Quantitative assessment of cerebral blood flow in patients with Alzheimer's disease
20. 18F scan in Alzheimer's disease and multi-infarct dementia
21. Brain energy metabolism and its significance for Alzheimer's disease
22. Senile dementia and Alzheimer's disease, brain blood flow and metabolism
23. Decreased concentrations of GLUT1 and GLUT3 glucose transporters in the brains of patients with Alzheimer's disease
24. Reduced glucose transporter at the blood brain barrier and in the cerebral cortex in Alzheimer's disease
25. Cerebral blood flow and oxygen metabolism in senile dementia of Alzheimer's type and vascular dementia with deep white matter changes
26. Misery perfusion with preserved vascular reactivity in Alzheimer's disease
27. Viability of neocortical function shown in behavioral activation state PET studies in Alzheimer's disease
28. Pathophysiology of the Alzheimer's syndrome
29. Astrocyte hypertrophy in the Alzheimer's disease hippocampal formation
30. The significance of glucose turnover in the brain in the pathogenic mechanisms of Alzheimer's disease
31. Brain energy metabolizing enzymes in Alzheimer's disease: α-Ketoglutarate dehydrogenase complex and cytochrome oxidase
32. Calcium in ischemic cell death
33. Glutamate uptake inhibition by oxygen free radicals in rat cortical astrocytes
34. ATP and brain function
35. In Alzheimer's disease the Golgi apparatus of a population of neurons without neurofibrillary tangles is fragmented and atrophic
36. The fragmented neuronal Golgi apparatus in ALS includes the trans-Golgi-network: Functional implications
37. erk converts tau into PHF-like form as found in Alzheimer's disease
38. Microvascular responses to cerebral ischemia/inflammation
39. 2+ homeostasis and cell death
40. Apolipoprotein E polymorphism and atherosclerosis
41. Relation of coronary atheroscleosis and apolipoprotein E genotypes in Alzheimer's disease
42. Lipoprotein and apolipoprotein profile in men with ischemic stroke
43. 4 is associated with the presence and earlier onset of hemorrhage in cerebral amyloid angiopathy
44. SPECT cerebral perfusion and apolipoprotein E genotype
45. Soluble Alzheimer's beta-amyloid constricts the cerebral vasculature in vivo
46. Presenilius, the endoplasmic reticulum and neuronal apoptosis in Alzheimer's disease
47. Presenilin 1-associated abnormalities in regional cerebral perfusion
48. Presenilin 1-associated abnormalities in regional cerebral perfusion
49. Relationship between neuronal activity, neuropathological hallmarks and genetic background in Alzheimer's disease
50. Risk factors for vascular disease and dementia
51. Regional cerebral blood flow and cerebrovascular risk factors in the elderly population
52. Hemodynamic consequences of deformed microvesseles in the brain in Alzheimer's disease
53. Differences in the effects of newborn piglet of various non-steroidal anti-inflammatory drugs on cerebral blood flow but not on cerebrovascular prostaglandins
54. Anatomical mapping of glucose transporter protein and pyruvate dehydrogenase in rat brain: An immunogold study
55. Quantitative immunocytochemistry (image analysis) of glucose transporters in the normal and postischemic rodent hippocampus
56. Capillary circulation in the brain
57. Reduced cytochrome oxidase and memory dysfunction after chronic brain ischemia in aged rats
58. Cytochrome oxidase: A predictive marker of neurodegeneration
59. Chronic reduction of cerebral blood flow in the adult rat: Late emerging CA1 cell loss and memory function
60. Critical threshold cerebral hypoperfusion causes Alzheimer's disease
61. Induction of neoangiogenesis in ischemic myocardium by human growth factors
62. bFGF increases collateral blood flow in aged rats with femoral artery ligation
63. Intrapericardial delivery of fibroblast growth factor-2 induces neovascularization in a porcine model of chronic myocardial ischemia
64. Basic fibroblast growth factor increases regional cerebral blood flow and reduces infarct size after experimental ischemia in a rat model
65. Therapeutic angiogenesis in ischemic heart disease
66. Combined internal mammary artery implantation and free omental graft operation: A highly effective revascularization procedure
67. Angiogenesis and the greater omentum
68. Vascular endothelial growth factor is the major angiogenic factor in omentum: Mechanism of the omentum-mediated angiogenesis
69. Regional cerebral blood flow after omental transposition to the ischemic brain in man
70. Omentum transposition to the brain for Alzheimer's disease
71. Angiogenic response induced by mechanical transmyocardial revascularization
72. Mechanism of action of transmyocardial revascularizatiom
73. Catheter-based percutaneous myocardial laser revascularization in patients with end-stage coronary artery disease
74. Channel patency and neovascularization after transmyocardial revascularization using an excimer laser
75. Physiological, histological and 2-weeks morphology of acute transmyocardial revascularization
76. Gene transfer of vascular endothelial growth factor and endothelial constituitive nitric oxide synthase-implications for gene therapy in cardiovascular diseases
77. Impaired microvascular perfusion in Alzheimer's disease: Role of constitutive nitric oxide
78. Functional arteries grown in vivo
79. Advances in tissue engineering of blood vessels and other tissues